IP Library Granted Patent US 10,676,443
Granted Patent B2
US 10,676,443 · App. 16/394,811 · Granted Jun 9, 2020

Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile

Inventors: Heiko Schirmer (Solingen, DE); Philipp Rubenbauer (Dusseldorf, DE); Birgit Keil (Dusseldorf, DE); Britta Olenik (Bottrop, DE)
Assignee: pH Pharma Co., Ltd.
C07D239/22C07C315/00C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,676,443
App. No.
16/394,811
Granted
Jun 9, 2020
Kind
B2
Abstract

The invention relates to a new and improved method for preparation of (4S)-4-[4-cyano-2-(methyl sulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile of formula (I), as well as the preparation and use of the crystal form (A) of (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile of formula (I).

Claims (13)

1. A method for preparing a compound of formula (XXVII)

comprising:

a) reacting a compound of formula (XXVI)

in the presence of a cinchona alkaloid and a solvent to form compounds of formulas (XXVIII) and (XXIX)

b) isolating a compound of formula (XXVIII); and

c) reacting the compound of formula (XXVIII) in the presence of a strong acid to form a compound of formula (XXVII), where R 1 in the compound of formulas (XXVI), (XXVII), (XXVIII) and (XXIX) is hydrogen or methyl.

2. The method of claim 1 , wherein the cinchona alkaloid is chosen from the group consisting of quinine and quinidine.

3. The method of claim 1 wherein R 1 in the compound of formulas (XXVI), (XXVII), (XXVIII) and (XXIX) is hydrogen.

4. The method of claim 1 wherein R 1 in the compound of formulas (XXVI), (XXVII), (XXVIII) and (XXIX) is methyl.

5. A compound of formula (XXVII)

wherein the compound is a quinidine salt and R 1 is hydrogen or methyl.

6. The compound of claim 5 wherein R 1 is hydrogen.

7. The compound of claim 5 wherein R 1 is methyl.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2024
From: THE THEO GROUP
To: PEAK BIO, INC.
Reel/Frame 069263/0109 →
SECURITY INTEREST Recorded Jul 23, 2024
From: PEAK BIO, INC.
To: THE THEO GROUP
Reel/Frame 068057/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2019
From: SCHIRMER, HEIKO; RUBENBAUER, PHILIPP; KEIL, BIRGIT; OLENIK, BRITTA
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 050602/0952 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2019
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: PH PHARMA CO., LTD.
Reel/Frame 050604/0527 →
Priority Claims (1)
EP 15159570 · Mar 18, 2015 · regional
Continuity (2)
Division 15559385
Related Publication 20190248750A1 · Aug 15, 2019